Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Best Practices in IHC-Based Tissue Image Analysis for Immuno-Oncology, Oncology, and Diabetes, New Webinar Hosted by Xtalks

BIOGY

TORONTO, ON--(Marketwired - December 17, 2014) - In this webinar, three unique case studies will be presented that demonstrate how IHC-based assays have been used to advance basic research and preclinical studies in diabetes, immuno-oncology, and oncology. There will be two live broadcasts on Wednesday, January 14, 2015, at 2pm GMT (9am EST), and 6pm GMT (1pm EST).

The use of advanced image analysis techniques with IHC assays is enabling robust quantitative analysis of biomarker expression and localization in tissue samples. Join the panel of experts for an information presentation.

Case Study 1: Development of an Encapsulated Cell Replacement Therapy for Diabetes

  • Anindita Bhoumik, Scientist, R&D, at ViaCyte, Inc., will review the development of a stem cell-based islet replacement therapy for treatment of patients with diabetes. She will address how advanced image analysis enabled product characterization with single and dual IHC staining.

Case Study 2: An Image Analysis Algorithm Based on the Hue Saturation Density Transformation, an Important Tool for Melanoma Immunotherapy Research

  • Dr. Jeff Dzubay Field Application Scientist at Definiens, will review how to improve melanoma research. He will demonstrate how to successfully separate red stained CD3 and CD8 positive immune cells from a background of brown melanocytes in TMA core samples from melanoma patients.

Case Study 3: Utilizing Definiens Tissue Studio® to Support Preclinical Assay Development for IHC-based Biomarkers

  • Douglas Bowman, Associate Scientific Fellow at Takeda Pharmaceuticals, will highlight the image analysis workflow deployed at Takeda for creating and analyzing IHC-based biomarkers. Using the PD assay workflow for context, he will highlight preclinical IHC image analysis and provide tips and tricks they have learned to get the most out of tissue image analysis.

To learn more about this event visit: Best Practices in IHC-based Tissue Image Analysis for Immuno-oncology, Oncology, and Diabetes

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2014/12/10/11G028321/Images/small_logo-276075653442.jpg

Contact:
Michelle Tran
Tel: +1 (416) 977-6555 ext 352
Email: mtran@xtalks.com